Puro has announced a £7million deal with UK-based IPS Pharma to export to the UK / Europe, signed at the New Zealand High Commission in London.
Speaking with Tom Forrest, Cultivation Director at Puro, he said:
“This is monumental for Puro, and the wider Aotearoa New Zealand cannabis sector. It’s exciting to see recognition from global industry for trusted, clean green Kiwi cannabis medicines.
Our entire team has worked tirelessly to showcase Puro cultivation and regulatory compliance, to best satisfy the needs of this growing market.
I’m excited to see what the NZ cannabis industry can achieve in the near future!”